IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $222,000 | +7.2% | 120,683 | +22.9% | 0.00% | – |
| Q4 2017 | $207,000 | -22.8% | 98,183 | -18.3% | 0.00% | -100.0% |
| Q3 2017 | $268,000 | +31.4% | 120,231 | +1.5% | 0.00% | – |
| Q2 2017 | $204,000 | -30.1% | 118,456 | +0.3% | 0.00% | -100.0% |
| Q1 2017 | $292,000 | +90.8% | 118,144 | +16.1% | 0.00% | – |
| Q4 2016 | $153,000 | -33.2% | 101,752 | +13.6% | 0.00% | -100.0% |
| Q3 2016 | $229,000 | +69.6% | 89,564 | +1.4% | 0.00% | – |
| Q2 2016 | $135,000 | -22.0% | 88,364 | +1.0% | 0.00% | -100.0% |
| Q1 2016 | $173,000 | -35.2% | 87,504 | +1.4% | 0.00% | 0.0% |
| Q4 2015 | $267,000 | +0.8% | 86,309 | +9.3% | 0.00% | 0.0% |
| Q3 2015 | $265,000 | -6.0% | 78,959 | +3.8% | 0.00% | 0.0% |
| Q2 2015 | $282,000 | +1.8% | 76,045 | +1.7% | 0.00% | 0.0% |
| Q1 2015 | $277,000 | +17.9% | 74,745 | +40.0% | 0.00% | 0.0% |
| Q4 2014 | $235,000 | +100.9% | 53,395 | +4.3% | 0.00% | – |
| Q3 2014 | $117,000 | -16.4% | 51,170 | +6.0% | 0.00% | – |
| Q2 2014 | $140,000 | – | 48,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|